Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 64(9): 5667-5688, 2021 05 13.
Article in English | MEDLINE | ID: mdl-33949859

ABSTRACT

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) that causes severe motor, sensory, and cognitive impairments. Kallikrein-related peptidase (KLK)6 is the most abundant serine protease secreted in the CNS, mainly by oligodendrocytes, the myelin-producing cells of the CNS, and KLK6 is assumed to be a robust biomarker of MS, since it is highly increased in the cerebrospinal fluid (CSF) of MS patients. Here, we report the design and biological evaluation of KLK6's low-molecular-weight inhibitors, para-aminobenzyl derivatives. Interestingly, selected hit compounds were selective of the KLK6 proteolytic network encompassing KLK1 and plasmin that also participate in the development of MS physiopathology. Moreover, hits were found noncytotoxic on primary cultures of murine neurons and oligodendrocyte precursor cells (OPCs). Among them, two compounds (32 and 42) were shown to promote the differentiation of OPCs into mature oligodendrocytes in vitro constituting thus emerging leads for the development of regenerative therapies.


Subject(s)
Cell Differentiation/drug effects , Kallikreins/antagonists & inhibitors , Serine Proteinase Inhibitors/pharmacology , Animals , Benzene Derivatives/chemistry , Benzene Derivatives/metabolism , Benzene Derivatives/pharmacology , Binding Sites , Catalytic Domain , Cells, Cultured , Drug Design , Fibrinolysin/antagonists & inhibitors , Fibrinolysin/metabolism , Humans , Kallikreins/metabolism , Kinetics , Mice , Molecular Docking Simulation , Multiple Sclerosis/metabolism , Multiple Sclerosis/pathology , Neurons/cytology , Neurons/metabolism , Oligodendroglia/cytology , Oligodendroglia/metabolism , Serine Proteinase Inhibitors/chemistry , Serine Proteinase Inhibitors/metabolism , Stem Cells/cytology , Stem Cells/metabolism , Structure-Activity Relationship
2.
Sci Rep ; 9(1): 14261, 2019 10 03.
Article in English | MEDLINE | ID: mdl-31582818

ABSTRACT

The relationship between the immune repertoire and the physiopathological status of individuals is essential to apprehend the genesis and the evolution of numerous pathologies. Nevertheless, the methodological approaches to understand these complex interactions are challenging. We performed a study evaluating the diversity harbored by different immune repertoires as a function of their physiopathological status. In this study, we base our analysis on a murine scFv library previously described and representing four different immune repertoires: i) healthy and naïve, ii) healthy and immunized, iii) autoimmune prone and naïve, and iv) autoimmune prone and immunized. This library, 2.6 × 109 in size, is submitted to high throughput sequencing (Next Generation Sequencing, NGS) in order to analyze the gene subgroups encoding for immunoglobulins. A comparative study of the distribution of immunoglobulin gene subgroups present in the four libraries has revealed shifts in the B cell repertoire originating from differences in genetic background and immunological status of mice.


Subject(s)
B-Lymphocytes/immunology , Genetic Background , Mice/genetics , Single-Chain Antibodies/immunology , Animals , Autoimmunity , B-Lymphocytes/metabolism , Gene Library , Immunization , Immunogenetic Phenomena , Mice/immunology , Mice, Inbred BALB C , Single-Chain Antibodies/genetics
3.
FEBS J ; 284(4): 634-653, 2017 02.
Article in English | MEDLINE | ID: mdl-28075071

ABSTRACT

ß-lactamase enzymes responsible for bacterial resistance to antibiotics are among the most important health threats to the human population today. Understanding the increasingly vast structural motifs responsible for the catalytic mechanism of ß-lactamases will help improve the future design of new generation antibiotics and mechanism-based inhibitors of these enzymes. Here we report the construction of a large murine single chain fragment variable (scFv) phage display library of size 2.7 × 109 with extended diversity by combining different mouse models. We have used two molecularly different inhibitors of the R-TEM ß-lactamase as targets for selection of catalytic antibodies with ß-lactamase activity. This novel methodology has led to the isolation of five antibody fragments, which are all capable of hydrolyzing the ß-lactam ring. Structural modeling of the selected scFv has revealed the presence of different motifs in each of the antibody fragments potentially responsible for their catalytic activity. Our results confirm (a) the validity of using our two target inhibitors for the in vitro selection of catalytic antibodies endowed with ß-lactamase activity, and (b) the plasticity of the ß-lactamase active site responsible for the wide resistance of these enzymes to clinically available inhibitors and antibiotics.


Subject(s)
Antibodies, Catalytic/chemistry , Penicillins/chemistry , Peptide Library , Single-Chain Antibodies/chemistry , beta-Lactamases/chemistry , beta-Lactams/chemistry , Amino Acid Sequence , Animals , Antibodies, Catalytic/biosynthesis , Antibodies, Catalytic/immunology , Catalytic Domain , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Hydrolysis , Immunization , Kinetics , Mice , Models, Molecular , Penicillins/administration & dosage , Penicillins/immunology , Protein Binding , Protein Interaction Domains and Motifs , Protein Structure, Secondary , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Single-Chain Antibodies/biosynthesis , Single-Chain Antibodies/immunology , Structure-Activity Relationship , Substrate Specificity , beta-Lactamases/biosynthesis , beta-Lactamases/immunology , beta-Lactams/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...